Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9194824 | 0.82 | — | — | |
| SCHEMBL12592351 | 0.77 | CSNK2A1 (0.38) | — | |
| SCHEMBL7526936 | 0.77 | CDK1 (0.35) | ALDH1A1 | |
| SCHEMBL14347071 | 0.77 | YTHDC1 (0.32) | — | |
| SCHEMBL10617981 | 0.77 | CSNK2A2 (0.33) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL31329224 | 0.76 | CSNK2A1 (0.37) | — | |
| SCHEMBL9937857 | 0.73 | GAA (0.32) | — | |
| SCHEMBL9937148 | 0.71 | LMNA (0.31) | — | |
| SCHEMBL18050703 | 0.71 | KDM4E (0.38) | — | |
| SCHEMBL18050702 | 0.71 | CYP1A2 (0.33) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030191086-A1 | Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof | USTAV EXPERIMENTALNI BOTANIKY AV CR | 2003-10-09 | — | — | US | claimed |
| EP-1147108-B1 | SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL USE THEREOF | USTAV EX BOTAN AKADEMIE VED CE (CZ) | 2003-08-13 | — | — | EP | claimed |
| EP-1147108-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL USE THEREOF | Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) | 2001-10-24 | — | — | EP | claimed |
| WO-2000043394-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL USE THEREOF | ÚSTAV EXPERIMENTÁLNÍ BOTANIKY AV CR (CZ) | 2000-07-27 | — | — | WO | claimed |
| US-4134792-A | Specific binding assay with an enzyme modulator as a labeling substance | MILES LABORATORIES, INC. (US) | 1979-01-16 | — | — | US | claimed |
| WO-2023092781-A1 | PREPARATION METHOD FOR REVERSE OSMOSIS MEMBRANE, AND REVERSE OSMOSIS MEMBRANE PREPARED THEREBY | 沃顿科技股份有限公司 | 2023-06-01 | — | — | WO | disclosed |
| CN-116159449-A | Method for preparing reverse osmosis membrane and reverse osmosis membrane prepared by same | 沃顿科技股份有限公司 | 2023-05-26 | — | — | CN | disclosed |
| US-20230104311-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-04-06 | — | — | US | disclosed |
| EP-4106763-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2022-12-28 | — | — | EP | disclosed |
| CN-115515593-A | Novel 6-substituted 7-deazapurines and corresponding nucleosides as medicaments | 勒芬天主教大学 | 2022-12-23 | — | — | CN | disclosed |
| US-20070197533-A1 | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds | ANADYS PHARMACEUTICALS, INC. (US) | 2007-08-23 | — | — | US | disclosed |
| US-7223759-B2 | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds | ANADYS PHARMACEUTICALS, INC. (US) | 2007-05-29 | — | — | US | disclosed |
| WO-2000043394-A1 | SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL USE THEREOF | ÚSTAV EXPERIMENTÁLNÍ BOTANIKY AV CR (CZ) | 2000-07-27 | — | — | WO | disclosed |
| US-5756253-A | PROCESSING OF DIFFUSION TRANSFER PHOTOGRAPHIC FILM UNITS IN PRESENCE OF HYPOXANTHINE AND INOSINE | POLAROID CORPORATION (US) | 1998-05-26 | — | — | US | disclosed |
| US-4724200-A | CRYSTAL STRUCTURE | EASTMAN KODAK COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4680255-A | Emulsions and photographic elements containing silver halide grains having tetrahexahedral crystal faces | EASTMAN KODAK COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4680256-A | Emulsions and photographic elements containing silver halide grains having trisoctahedra crystal faces | EASTMAN KODAK COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4680254-A | Emulsions and photographic elements containing silver halide grains having hexoctamedral crystal faces | EASTMAN KODAK COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4134792-A | Specific binding assay with an enzyme modulator as a labeling substance | MILES LABORATORIES, INC. (US) | 1979-01-16 | — | — | US | disclosed |
| US-4001031-A | CHLORINATED ORGANIC FUEL CONVERTS POTASSIUM OXIDE TO POTASSIUM CHLORIDE | CHEM-TROL POLLUTION SERVICES, INC. (US) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191086-A1 | Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof | CDK4, CDK5, CCNI | ALDH1A1 4084/4885ALOX15 3898/4885TSHR 3907/4885 |
| US-20070197533-A1 | Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds | DDC, DPP3, AMPD3 | ALDH1A1 2233/4885ALOX15 2890/4885TSHR 4325/4885 |
| US-20230104311-A1 | NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS | ADA, ADAR, TPMT | ALDH1A1 444/4885ALOX15 3059/4885TSHR 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.